Chronic Leukemia Perspective

• Episode 6: Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma   Drs Peter Martin and Anita Kumar discuss covalent and noncovalent Bruton tyrosine kinase (BTK) inhibitors in the frontline setting, BTK mutations, and the complicated mechanisms of resistance.
  Medscape, May 31, 2023
• Racial Disparities in CLL: Underrepresentation in Clinical Trials   Joanna Rhodes, MD, MSCE observes differences in the disease biology of chronic lymphocytic leukemia in younger Black patients and emphasizes the need for enrolling non-White patients in clinical trials and ongoing research.
  Medscape, May 30, 2023
• A Path to a Career in CLL Clinical Research   Joanna Rhodes, MD, MSCE, narrates a change in focus from acute leukemias and bone marrow transplants to the field of chronic lymphocytic leukemia.
  Medscape, May 30, 2023
• Improving Quality of Life in Patients With CLL: Managing Side Effects From Targeted Therapy   Joanna Rhodes, MD, MSCE, reflects on a patient who experienced side effects from targeted agents for chronic lymphocytic leukemia.
  Medscape, May 30, 2023
• The Costs of Disparities in the Treatment of Chronic Lymphocytic Leukemia   Seema Bhat, MD, reflects on the inequities of access to treatment and deficiencies in research for chronic lymphocytic leukemia.
  Medscape, May 30, 2023
• How Collaboration Builds Better Treatments for Chronic Lymphocytic Leukemia   Seema Bhat, MD, comments on the character of collaboration in the development of therapies for chronic lymphocytic leukemia.
  Medscape, May 30, 2023
• Learning to Appreciate the Impact of CLL on the Lives of Patients   Kerry Rogers, MD, reflects on what she underestimated about CLL when she first started seeing patients as a fellow.
  Medscape, May 30, 2023
• Taking the Long View in the Treatment of CLL   Kerry A. Rogers, MD, considers the impact of a constantly advancing therapeutic scene in chronic lymphocytic leukemia.
  Medscape, May 30, 2023
• Episode 5: Key Topics in the Pathology of Mantle Cell Lymphoma   Drs Peter Martin and Eric Hsi have a thought-provoking discussion on key topics in the pathology of mantle cell lymphoma, including biopsies, diagnostic markers, and what the future holds for treatment.
  Medscape, April 27, 2023
• Episode 1: Autologous Stem Cell Transplant for Mantle Cell Lymphoma   Drs Peter Martin and Brad Kahl discuss autologous stem cell transplantation for mantle cell lymphoma, the TRIANGLE trial results, and the transition toward use of Bruton tyrosine kinase inhibitors.
  Medscape, January 31, 2023
• Chronic Lymphocytic Leukemia Highlights From ASH 2022   Dr Jan Burger reports on key data in chronic lymphocytic leukemia from ASH 2022, focusing on treatment-free remission, triple combination therapy, and BTK inhibitors pirtobrutinib and zanubrutinib.
  Medscape, January 04, 2023
• CLL e-Tumor Boards: Case 2: Relapsed Chronic Lymphocytic Leukemia   This case focuses on a woman who was diagnosed with CLL in her late 50s. She was initially observed for one year and received treatment with a chemoimmunotherapy combination. She relapsed twice before. Now in her 70s, she presents to the team with progressive disease and is seeking new treatment options.
  Medscape, November 21, 2022
• Paxlovid Rebound in COVID-19: Where We Stand on Drug Regimens   Drs Robert Glatter and Paul Auwaerter discuss Paxlovid rebound and recommendations for patients with COVID-19.
  Medscape Emergency Medicine, September 01, 2022
• Is the Phrase 'A Cure for Cancer' Outdated?   WebMD's Chief Medical Officer, John Whyte, MD, speaks with Sanjay Juneja, MD, Chief of Oncology, Baton Rouge General Hospital, about multiple strategies and treatments for cancer and why the phrase 'a cure for cancer' might be outdated.
  WebMD, August 31, 2022
• CLL e-Tumor Boards: Case 1: Stage II Chronic Lymphocytic Leukemia   This case focuses on a man who was diagnosed with CLL in his 40s, after his labs showed a leukocytosis with a lymphocyte predominance as well as cervical and inguinal adenopathy. The team discusses testing for CLL, first-line therapy options, and ongoing clinical trials.
  Medscape, July 15, 2022
• EHA 2022 Read clinically focused news coverage of key developments from EHA 2022
  Medscape Oncology, June 07, 2022
• Episode 1: Screening for Early-Stage Multiple Myeloma   Joseph Mikhael, MD, and Irene Ghobrial, MD, discuss screening high-risk populations for early-stage multiple myeloma and new techniques to detect it.
  Medscape, May 03, 2022
• Outlook on Chronic Lymphocytic Leukemia: How Clinical Trials Can Improve Patient Outcomes   Deborah M. Stephens, DO, considers the role of clinical trials both in the development of more effective therapies and the often dramatically improved outcomes of their participants.
  Medscape, February 11, 2022
• How Experiences With Richter Transformation Shaped a Clinician's Day-to-Day Practice   Deborah M. Stephens, DO, shares how the suffering of a family member with CLL inspired her to be an aggressive advocate for getting her patients access to clinical trials and beneficial therapies.
  Medscape, February 11, 2022
• Outlook on Chronic Lymphocytic Leukemia: From Theory to Practice   Deborah M. Stephens, DO, reflects on how involvement in a mentor's clinic prompted her to focus on chronic lymphocytic leukemia.
  Medscape, February 10, 2022